Buscar
01/09/2024
A Decade of Monitoring Primary Healthcare Experiences through the Lens of Inequality
Pasarín, MI, Rodríguez-Sanz, M, Berra, S, Borrell, C, Rocha, KB. A Decade of Monitoring Primary Healthcare Experiences through the Lens of Inequality. Healthcare. 2024; 12(18)DOI:10.3390/healthcare12181833. PMID:39337174. IF:2.700(Q2/4D).
01/09/2024
Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes
Miró, O, Núñez, J, Trullàs, JC, Lopez-Ayala, P, Llauger, L, Alquézar-Arbé, A, Miñana, G, Mollar, A, de la Espriella, R, Lorenzo, M, Jacob, J, Espinosa, B, Garcés-Horna, V, Aguirre, A, Fortuny, MJ, Martínez-Nadal, G, Gil, V, Mueller, C, Llorens, P. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes. European Journal of Internal Medicine. 2024; 127DOI:10.1016/j.ejim.2024.05.009. PMID:38763846. IF:6.100(Q1/1D).
01/09/2024
Challenges and opportunities in the development and clinical implementation of artificial intelligence based synthetic computed tomography for magnetic resonance only radiotherapy
Villegas, F, Dal Bello, R, Alvarez-Andres, E, Dhont, J, Janssen, T, Milan, L, Robert, C, Salagean, GAM, Tejedor, N, Trnková, P, Fusella, M, Placidi, L, Cusumano, D. Challenges and opportunities in the development and clinical implementation of artificial intelligence based synthetic computed tomography for magnetic resonance only radiotherapy. RADIOTHERAPY AND ONCOLOGY. 2024; 198DOI:10.1016/j.radonc.2024.110387. PMID:38885905. IF:5.300(Q1/2D).
01/09/2024
Clinical management of patients with Perugini grade 1 on [99mTc]-HDP cardiac scintigraphy
Calahorro, MC, Stefaneli, P, Camacho, V, Velasco, M, Duch, J, Fern ndez, A, Soldevila, C, Guzm n, G, Castej n, S, Maestro, A, Mirabet, S, Flotats, A. Clinical management of patients with Perugini grade 1 on [99mTc]-HDP cardiac scintigraphy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024
Clinical impact of [18F]FDG PET/CT for initial staging in breast cancer patients prior to neoadjuvant chemotherapy
Renom, JD, Stefaneli, P, Calls, M, Camacho, V, Guzm n, G, Andr s, M, Le n, AF, Soldevila, C, Velasco, M, Castej n, S, Flotats, A. Clinical impact of [18F]FDG PET/CT for initial staging in breast cancer patients prior to neoadjuvant chemotherapy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024
[18F]FDG-PET/CT in Giant Cell Arteritis. Which vascular segmental quantitative parameter is most useful?
Nu o, MV, Fern ndez-Le n, A, Alvarado, PM, Stefaneli, P, Calahorro, MC, Park, HS, Barros-Membrilla, A, Prudencio, GG, Camacho, V, Duch, J, Soldevila-Lozano, C, Echevarne, SC, Lopez, BM, Barranco, IC, Mendez, HC, Macias, HC, Flotats, A. [18F]FDG-PET/CT in Giant Cell Arteritis. Which vascular segmental quantitative parameter is most useful?. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024
Tau PET deposition measured by [18F]PI-2620 increases along the Alzheimer's disease continuum in Down Syndrome
Camacho, V, Vaqu , L, Stefaneli, P, Calls, M, Fernandez, A, Duch, J, Barroeta, I, Carmona, M, Velasco, M, Soldevila, C, Guzm n, G, Castej n, S, Bejanin, A, Lle , A, Fortea, J, Flotats, A. Tau PET deposition measured by [18F]PI-2620 increases along the Alzheimer's disease continuum in Down Syndrome. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024
Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection
Casanovas, MM, L pez, J, Jimenez-Fonseca, P, Pubul, V, Bello, P, Garc a-Burillo, A, Valverde, R, Llana, B, Percovich, J, Soldevila, C, Arbizu, J, Pi eiro, A, Castell n, M, Ordu a, P, Cano, J, Tabuenca, M, Rodado, S, Garcia-Ca amaque, L, Nevares, M, Balaguer, D, Gomez, D, Hernando, J, Repetto, A, Nogareda, Z, Carmona-Bayonas, A. Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).